Category: Antibodies

Filter By
Categories: Antibody panels Categories: Intracellular Functional Antibodies Categories: Isotype Controls Clear all
Sibeprenlimab Sibeprenlimab

Sibeprenlimab

Reference: HY-P99901
€0.00 (tax incl.)
Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody. Sibeprenlimab can inhibit APRIL. Sibeprenlimab can be used for the research of IgA nephropathy (IgAN).
Organelle Marker Antibody Panel Organelle Marker Antibody Panel

Organelle Marker Antibody Panel

Reference: GTX300001
€0.00 (tax incl.)
Poly(ADP-ribosyl)transferase (PARP1) is a chromatin-associated enzyme, which modifies various nuclear proteins by poly(ADP-ribosyl)ation. This antibody is a control for nuclear localization. PARP1 has a molecular...
Tengonermin Tengonermin

Tengonermin

Reference: HY-P99565
€0.00 (tax incl.)
Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and...
Tinurilimab Tinurilimab

Tinurilimab

Reference: HY-P99051
€0.00 (tax incl.)
Tinurilimab (Bay 1834942) is an anti-CEACAM6 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors.
Ralpancizumab Ralpancizumab

Ralpancizumab

Reference: HY-P99816
€0.00 (tax incl.)
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.
Glenzocimab Glenzocimab

Glenzocimab

Reference: HY-P99644
€0.00 (tax incl.)
Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke.
Pepinemab Pepinemab

Pepinemab

Reference: HY-P99407
€0.00 (tax incl.)
Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular...
Bepranemab Bepranemab

Bepranemab

Reference: HY-P99471
€0.00 (tax incl.)
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research.
Efgivanermin alfa Efgivanermin alfa

Efgivanermin alfa

Reference: HY-P99907
€0.00 (tax incl.)
Efgivanermin alfa is an active peptide. Efgivanermin alfa can be used for various biochemical studies.
Namilumab Namilumab

Namilumab

Reference: HY-P99307
€0.00 (tax incl.)
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis.
Lirentelimab Lirentelimab

Lirentelimab

Reference: HY-P99371
€0.00 (tax incl.)
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated...
Garivulimab Garivulimab

Garivulimab

Reference: HY-P99633
€0.00 (tax incl.)
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity.
Cudarolimab Cudarolimab

Cudarolimab

Reference: HY-P99836
€0.00 (tax incl.)
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has...
Actoxumab Actoxumab

Actoxumab

Reference: HY-P99277
€0.00 (tax incl.)
Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response,...
Vorsetuzumab Vorsetuzumab

Vorsetuzumab

Reference: HY-P99273
€0.00 (tax incl.)
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.
Aldafermin Aldafermin

Aldafermin

Reference: HY-P99428
€0.00 (tax incl.)
Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH).
Diridavumab Diridavumab

Diridavumab

Reference: HY-P99853
€0.00 (tax incl.)
Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research...
Clesrovimab Clesrovimab

Clesrovimab

Reference: HY-P99804
€0.00 (tax incl.)
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection.
Ivuxolimab Ivuxolimab

Ivuxolimab

Reference: HY-P99159
€0.00 (tax incl.)
Ivuxolimab is an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4+ and CD8+ T cells. Ivuxolimab shows antitumor activity, with potential...
Nivolumab (anti-PD-1) Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1)

Reference: HY-P9903A
€0.00 (tax incl.)
Nivolumab (anti-PD-1) is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Xeligekimab Xeligekimab

Xeligekimab

Reference: HY-P99515
€0.00 (tax incl.)
Xeligekimab (GR 1501) is an anti-human interleukin 17A (IL-17A) humanized monoclonal antibody. Xeligekimab inhibits the pro-inflammatory cascade.
Acasunlimab Acasunlimab

Acasunlimab

Reference: HY-P99419
€0.00 (tax incl.)
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1...
Rovalpituzumab Rovalpituzumab

Rovalpituzumab

Reference: HY-P99043
€0.00 (tax incl.)
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity...
Verpasep caltespen Verpasep caltespen

Verpasep caltespen

Reference: HY-P99522
€0.00 (tax incl.)
Verpasep caltespen (HspE7) is a recombinant fusion protein derived from Mycobacterium bovis Calmette-Guérin heat shock protein 65 (Hsp65), the C-terminal end of which is covalently linked to the E7 protein of HPV16....
Belantamab Belantamab

Belantamab

Reference: HY-P9980
€0.00 (tax incl.)
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin.
Pertuzumab Pertuzumab

Pertuzumab

Reference: HY-P9912
€0.00 (tax incl.)
Pertuzumab, a humanized IgG1 monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
Giloralimab Giloralimab

Giloralimab

Reference: HY-P99640
€0.00 (tax incl.)
Giloralimab (ABBV-927) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab has the potential for the research of cancer.
Alemtuzumab Alemtuzumab

Alemtuzumab

Reference: HY-P9948
€0.00 (tax incl.)
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52, a glycoprotein expressed on the surface of most lymphoid, and to a lesser extent, myeloid cell types. Alemtuzumab selectively targets the CD52...
Upifitamab Upifitamab

Upifitamab

Reference: HY-P99229
€0.00 (tax incl.)
Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer...
Obinutuzumab Obinutuzumab

Obinutuzumab

Reference: HY-P9910
€0.00 (tax incl.)
Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.
Nimacimab Nimacimab

Nimacimab

Reference: HY-P99755
€0.00 (tax incl.)
Nimacimab (RYI-018) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases.
Rontalizumab Rontalizumab

Rontalizumab

Reference: HY-P99267
€0.00 (tax incl.)
Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
Olinvacimab Olinvacimab

Olinvacimab

Reference: HY-P99768
€0.00 (tax incl.)
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the...
Budigalimab Budigalimab

Budigalimab

Reference: HY-P99489
€0.00 (tax incl.)
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function.
Unasnemab Unasnemab

Unasnemab

Reference: HY-P99959
€0.00 (tax incl.)
Unasnemab (MT-3921) is a humanised IgG1 monoclonal antibody that binds to repulsive guidance molecule A (RGMa). Unasnemab improves locomotor function and promotes neuroregeneration and can be used for the research of...

Menu

Settings

Please sign in first.

Sign in